Docetaxel in the management of advanced or metastatic urothelial tract cancer. [electronic resource]
Producer: 20030210Description: 107-11 p. digitalISSN:- 0890-9091
- Antineoplastic Agents, Phytogenic -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Cisplatin -- administration & dosage
- Clinical Trials, Phase II as Topic
- Deoxycytidine -- administration & dosage
- Docetaxel
- Humans
- Paclitaxel -- adverse effects
- Taxoids
- Urologic Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.